4 results  1 of 1 

1 Apixaban for Secondary Stroke Prevention: Coexistant Cerebral Atherosclerosis May Increase Recurrent Strokes
Jong S. Kim, Jaseong Koo, Dong-Ick Shin, Byung-Su Kim, Jei Kim, Eung-Gyu Kim, Keun-Sik Hong, Hyeju Yi
J Stroke.2022;24(1):118-127.   Published online 2022 January 31     DOI: http://dx.doi.org/10.5853/jos.2021.02355
      
2 Refractory Ascites with Intrahepatic Portal Thrombosis after Living Donor Liver Transplantation Successfully Treated by Splenic Artery Embolization and Apixaban (Case Report)
Hyung Hwan Moon
Kosin Med J.2021;36(2):187-192.   Published online 2021 December 31     DOI: http://dx.doi.org/10.7180/kmj.2021.36.2.187
      
3 Comparison of Apixaban and Low Molecular Weight Heparin in Preventing Deep Venous Thrombosis after Total Knee Arthroplasty in Older Adults
Hui Jiang, Jia Meng, Ting Guo, Jian-ning Zhao, Yi-cun Wang, Jun Wang, Yang Qiu, Hao Ding
Yonsei Med J.2019;60(7):626-632.   Published online 2019 June 24     DOI: http://dx.doi.org/10.3349/ymj.2019.60.7.626
      
4 Quantification of apixaban in human plasma using ultra performance liquid chromatography coupled with tandem mass spectrometry
Hyeon-Cheol Jeong, Tae-Eun Kim, Kwang-Hee Shin
Transl Clin Pharmacol.2019;27(1):33-41.   Published online 2019 March 27     DOI: http://dx.doi.org/10.12793/tcp.2019.27.1.33
      

 1 of 1